Stocks and Investing Stocks and Investing
Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022

Aaron Gal Maintained (ABBV) at Buy with Increased Target to $155 on, Jan 3rd, 2022


Published on 2024-10-27 19:06:57 - WOPRAI, Aaron Gal
  Print publication without navigation


Aaron Gal of Bernstein, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $130 to $155 on, Jan 3rd, 2022.

Aaron has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 3 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $113 on, Friday, December 17th, 2021
  • Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021


These are the ratings of the 6 analyists that currently disagree with Aaron


  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
  • Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $132 on, Monday, November 1st, 2021